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Background: Epidemiologic studies and studies in rodents point to potential risks from 
developmental exposure to BPA on cardiometabolic diseases. Furthermore, it is becoming 
increasingly evident that the manifestation and severity of adverse outcomes is the result of 
interaction between developmental insults and the prevailing environment. Consistent with this 
premise, recent studies in sheep found prenatal BPA treatment prevented the adverse effects of 
postnatal obesity in inducing hypertension. The gene networks underlying these complex 
interactions are not known. Methods: mRNA-seq of myocardium was performed on four groups 
of four female sheep to assess the effects of prenatal BPA exposure, postnatal overfeeding and 
their interaction on gene transcription, pathway perturbations and functional effects. Results: 
The effects of prenatal exposure to BPA, postnatal overfeeding, and prenatal BPA with postnatal 
overfeeding all resulted in transcriptional changes (85 - 141 significant differentially expressed 
genes). Although the effects of prenatal BPA and postnatal overfeeding did not involve 
dysregulation of many of the same genes, they affected a remarkably similar set of biological 
pathways. Furthermore, an additive or synergistic effect was not found in the combined 
treatment group, but rather prenatal BPA treatment led to a partial reversal of the effects of 
overfeeding alone. Many genes previously known to be affected by BPA and involved in obesity, 
hypertension, or heart disease were altered following these treatments, and AP-1, EGR1, and 
EGFR were key hubs affected by BPA and/or overfeeding. 
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The World Health Organization estimates that by the year 2030, on a global basis, more than 23 
million people will die annually from cardiovascular diseases (CVD) [WHO 2016 
http://www.who.int/cardiovascular_diseases/about_cvd/en]. In the United States, CVD is already 
responsible for a very substantial portion of national health care expenditures, with CVD and 
stroke accounting for more than $315.4 billion in 2010 [Go et al. 2014]. In addition, despite the 
perception that men tend to be susceptible to CVD and women tend to be protected, CVD-related 
death is one of the leading causes of mortality for both women and men in developed countries. 
In fact, CVD is among the top 4 causes of death among women aged 25-54 years [Leading cause 
of death in women, CDC, http://www.cdc.gov/women/lcod/index.htm] and in the past 2-3 
decades, the incidence of myocardial infarction has increased significantly in young women 
[Ablewska et al. 2011]. In the INTERHEART study on patients from 52 countries, nine 
modifiable risk factors were found to account for 94% of attributable risk for a woman having 
her first myocardial infarction including: dyslipidemia, hypertension, diabetes, and abdominal 
obesity [Yusuf et al. 2004]. 
 
Intrauterine and early environmental influences may be major contributors to the development of 
adult CVD [Alexander et al. 2015; Blackmore and Ozanne 2015] and its risk factors, and 
environmental endocrine disrupting chemicals (EDCs) are receiving considerable attention in 
this context [Ranciere et al. 2015]. Common sources of these environmental exposures include 
the use of anabolic steroids [Hartgens and Kuipers 2004], contraceptives [Waller et al. 2010], 
and unintended exposure to environmental steroid mimics through food sources or industrial 
pollutants [Hotchkiss et al. 2008; O'Toole et al. 2008; Cosselman et al. 2015]. One of the most 
Page 3 of 47
John Wiley & Sons, Inc.
Environmental and Molecular Mutagenesis












controversial EDCs is bisphenol A (BPA), a component of polycarbonate plastic and epoxy 
resins used in the manufacture of many consumer products [Vandenberg et al. 2013]. Humans 
are exposed ubiquitously to BPA via diet, dust, air, and water, as well as exposures as routine as 
handling cash receipts [Vandenberg et al. 2010]. BPA has been found to act as an estrogen, anti-
androgen, and has been shown to affect thyroid function and induce hyperinsulinemia [Acconcia 
et al. 2015]. Questions about potential health risks from developmental exposure to BPA are 
raised from studies reporting the presence of BPA in human maternal circulation [Padmanabhan 
et al. 2008; Vandenberg et al. 2010], human tissues [Othman et al. 2016], amniotic and placental 
fluids [Ikezuki et al. 2002], breast milk [Sun et al. 2004], and the urine of neonates [Calafat et al. 
2009]. All of these sources represent exposures during critical early developmental windows, 
which could have very significant long-term health implications. 
 
Epidemiologic and animal studies point to potential risks from early BPA exposures on 
development of obesity, diabetes, and cardiometabolic diseases [Rezg et al. 2014; Ranciere et al. 
2015; Song et al. 2015]. Because epidemiologic studies can point to potential associations but 
cannot address causality, the impact of developmental exposure to BPA has been tested in 
animal models - primarily in rodents. Considering the marked differences in cardiac physiology 
between rodents and larger species such as human and sheep [Hew and Keller 2003] and the 
recent concerns expressed over use of altricial models such as rats for translating findings to 
humans [Habert et al. 2014], it is necessary to undertake cross-species comparisons for human 
translation [Neier et al. 2015]. An example is the cross-species comparison performed in our 
recent study [Veiga-Lopez et al. 2015b], which also included a precocial species. Our group and 
others have extensively used sheep as a model to address the impact of developmental insults 
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stemming from under and over-nutrition [Symonds et al. 2001; Metges 2009; Nathanielsz et al. 
2013] as well as abnormal exposure to excess steroids [Padmanabhan and Veiga-Lopez 2013] on 
metabolic outcomes. Our studies in sheep found that prenatal exposure to excess testosterone, a 
hormone that is also a precursor for estrogen, from days 30-90 of gestation leads to low birth 
weight offspring, reproductive defects, insulin resistance [Padmanabhan and Veiga-Lopez 2013] 
and hypertension [King et al. 2007] thereby establishing the critical window for programming 
adult reproductive and metabolic defects. Using the same critical window of exposure, our 
studies also found prenatal BPA treatment at levels found in humans [Padmanabhan et al. 2008] 
induced insulin resistance and adipocyte hypertrophy [Veiga-Lopez et al. 2016]. Identification of 
a critical window for programming cardiometabolic dysfunctions in sheep provides a suitable 
model for testing the developmental impact of BPA exposure.  
 
Increasingly, evidence indicates that manifestation of final phenotypic outcomes is not only the 
result of early developmental insults but also a function of the prevailing postnatal environment 
[Padmanabhan et al. 2016]. As such, the prevalence and rise of childhood obesity [Hruby and Hu 
2015] creates the metabolic platform for amplifying metabolic disruptions programmed by 
developmental BPA exposures, or alternatively, prenatal BPA treatment can modulate the 
responsiveness to postnatal insults. Recently we found that while prenatal BPA increases the 
gene expression of atrial natriuretic peptide (ANP) in the ventricles of female sheep, it blocked 
the postnatal obesity-induced increase in diastolic blood pressure and left ventricular surface area 
[MohanKumar et al. 2016]. Because the sheep heart is one of the most commonly used large 
animal models for studying CVD [Thornburg et al. 2008; Papamatheakis et al. 2013; Albertine 
2015; Bensley et al. 2016], the aim of this study was to follow up on the paradoxical interaction 
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between prenatal BPA and postnatal obesity and to gain a comprehensive understanding of both 
the impact of gestational exposure to BPA on the myocardial transcriptome and the interaction of 
postnatal obesity in modulating these effects. 
 
Materials and Methods 
Breeding, prenatal treatment, and maintenance: All procedures used in this experiment were 
approved by the University Committee on Use and Care of Animals (UCUCA), at the University 
of Michigan. The study was carried out at the University of Michigan Sheep Research Facility 
(Ann Arbor, MI; 42º 18´N). Breeder ewes were purchased from a local farm, blocked by weight 
and body score and randomized to control or BPA treatment groups. Ewes were bred by fertility-
proven rams and paint markings left on the rumps of ewes by the raddled rams allowed us to 
determine the day of mating. BPA treatment spanned days 30 through 90 of gestation (term: ~ 
147 days) and consisted of daily subcutaneous injections of 0.5 mg/kg/day of BPA (purity ≥ 
99%, cat# 239658; Aldrich Chemical Co., Milwaukee, WI), with corn oil as the vehicle. 
Concentrations of unconjugated BPA achieved in umbilical arterial samples using the 0.5 
mg/kg/day dose averaged 2.6 ng/mL and has been previously reported [Veiga-Lopez et al. 2013]. 
These levels approach both the median level of BPA measured in maternal circulation of US 
women [Padmanabhan et al. 2008] and the median level of BPA measured in urine of US women 
[Calafat et al. 2005]. Pregnant ewes in the control group were administered vehicle alone. 
 
Common conditions: To avoid confounding effects from differences in feeds, all feed was 
purchased in bulk. Beginning six weeks before the expected date of delivery and continuing until 
the time of delivery, pregnant ewes were group-fed 0.5 kg shelled corn, 2 kg alfalfa hay and 250 
mg aureomycin crumbles (chlortetracycline)/ewe/day. Lactating ewes were fed 1 kg shelled corn 
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and 2-2.5 kg of alfalfa hay/ewe/day. All lambs and ewes were provided with water and minerals 
ad libitum and were treated regularly with anthelmintic to minimize parasitic infection. After 
weaning at ~2 months, all lambs were subsequently maintained outdoors at the Sheep Research 
Facility (Ann Arbor, MI, USA; 42°, 18'N). From weaning to 14 weeks of age, all lambs had ad 
libitum access to commercial feed pellets (Shur-Gain, Elma, NY, USA; contains 18% crude 
protein) and alfalfa hay. Animals from this cohort have been used in studies addressing the 
impact of prenatal BPA and postnatal adiposity on insulin sensitivity and adipocyte morphology 
[Veiga-Lopez et al. 2016] as well as cardiovascular function [MohanKumar et al. 2016]. 
 
Treatment groups: The study consisted of four treatment groups: controls (vehicle-treated and 
maintenance-fed: n = 11), prenatal BPA-treated and maintenance-fed (BPA: n = 8), control-
overfed (no prenatal BPA-treatment but overfed (C+OF: n = 11)) or prenatal BPA-treated and 
overfed (BPA+OF: n = 11). When twin birth was involved, they were distributed between the 
maintenance-fed and overfed groups such that only one lamb from each dam was included in a 
given group. 
 
The daily diet of the maintenance-fed animals (C, BPA), on a per lamb basis, consisted of 1.4 lbs 
corn, 0.03 lbs of supplement (36% crude protein), and 1.4 lbs hay. The daily diet of overfed 
animals (C+OF, BPA+OF) consisted of 1.7 lbs corn, 0.03 lbs of supplement, and 1.6 lbs hay 
initially and then ad libitum. The diet for the maintenance-fed animals was designed to achieve 
optimal growth without excess fat deposition, while the diet for the overfed animals was 
designed to make them obese - a body weight ~25% above that of normal weight adult female 
sheep. To compensate for increased energy demands as the lambs grew, and to meet additional 
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energy demands during inclement weather, the ration was increased in control-fed and overfed 
females by the same percentages. 
 
Harvesting of heart tissue was conducted during the second breeding season, when the selected 
animals were 21 months old. All animals were given two intramuscular injections of 
Prostaglandin F2α (PGF2α 20 mg, Lutalyse, Pfizer Animal Health, NY, USA), 11 days apart, to 
induce luteolysis and synchronize the initiation of the follicular phase in cycling females. All 
animals were weighed prior to euthanasia. Ewes were euthanized 27 h after the second PGF2α 
injection, during the presumptive follicular phase, by administration of a barbiturate overdose 
(Fatal Plus, Vortech Pharmaceuticals, Dearborn, MI). Hearts were quickly dissected out and 
weighed, then chunks of left ventricular free wall myocardium were harvested from a randomly 
selected subset of four animals per group (n=4 for each of the control, BPA, C+OF, and 
BPA+OF groups) and snap frozen in the 2-Methylbutane/isopentane (Sigma-Aldrich)-dry ice 
bath and stored in -80 freezer until processed. 
 
RNA extraction: Total RNA was extracted from the frozen myocardium using TRIzol Reagent 
(Life Technologies, Carlsbad, CA) according to the manufacturer’s instructions. The 
concentration of RNA from each sample was measured by NanoDrop 2000 UV-Vis 
Spectrophotometer (Thermo Scientific, Waltham, MA). OD 260/280 values were 1.87 - 1.96 for 
the RNA samples. The integrity of each RNA sample was monitored through Agilent BioA RNA 
Integrity Number (RIN) (Agilent Technologies, Santa Clara, CA). 
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RNA-Seq library construction: RNA-Seq was performed by the Genomics, Epigenomics and 
Sequencing Core (GESC) at the University of Cincinnati. Using the TruSeq RNA sample 
preparation kit (Illumina, San Diego, CA), one µg of total RNA with RIN (Agilent 2100 
Bioanalyzer) ≥ 7.0 was used to purify poly-A containing mRNA using poly-T oligo-attached 
magnetic beads. The purified mRNA was enzymatically fragmented and random hexamers-
primed for the first and second strand cDNA synthesis, followed by purification using Agencourt 
AMPure XP beads (Beckman Coulter, Southfield, MI).The double-strand cDNA with overhangs 
was converted into blunt ends in the end repair procedure, and adenylated to add a single "A" 
nucleotide at 3' ends to prevent them from self-ligation in the following ligation step. The 
AMPure XP beads-purified fragments were then ligated to sample-specific indexing adapters, 
and enriched by 10 cycles of PCR using adapter-specific primers. 
 
One µl of purified PCR product (sequencing library, total 30 µl) was analyzed by Bioanalyzer 
(Agilent) using the DNA 1000 chip to check the DNA fragment size (~260 bp) and yield. To 
accurately quantify the library concentration for the clustering, the library was 1:104-106 diluted 
in dilution buffer (10 mM Tris-HCl, pH 8.0 with 0.05% Tween 20), and qPCR analyzed by the 
Kapa Library Quantification kit (Kapa Biosystems, Wilmington, MA) using ABI's 9700HT real-
time PCR system (Thermo Fisher Scientific, ). 
 
Cluster Generation and HiSeq Sequencing: The sixteen individually indexed cDNA libraries 
were pooled for clustering in the cBot system (Illumina). Libraries were clustered at a 
concentration of 8 pM using Illumina’s TruSeq SR Cluster Kit v3, and sequenced for 50 cycles 
using TruSeq SBS kit on Illumina HiSeq system. The number of reads generated per sample 
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ranged from 21 – 69 million. The raw fastq files have been submitted to NCBI’s Short Read 
Archive (SRA) with accession GSE77418. 
 
RNA-seq pre-processing and differential expression analysis: Raw fastq files were checked for 
quality using FastQC (version 0.10.0) [Babraham] to identify features of the data that may 
indicate quality problems (e.g. low quality scores, over-represented sequences, inappropriate GC 
content, etc.). The Tuxedo Suite software package was used for alignment, differential 
expression analysis, and post-analysis diagnostics [Langmead et al. 2009; Trapnell et al. 2009; 
Trapnell et al. 2013]. Briefly, reads were aligned to the reference transcriptome (Ensembl 
Oar_v3.1) [Cunningham et al. 2015] using TopHat (version 2.0.9) and Bowtie (version 2.1.0). 
Default parameter settings were used for alignment, with the exceptions of: “--b2-very-
sensitive”, which allows extra time to search for valid alignments, and “--no-coverage-search” 
and “--no-novel-juncs” which restricts the mapping to known transcripts. The percent uniquely 
aligned ranged from 65-68%. FastQC was used for a second round of quality control (post-
alignment), to ensure that only high quality data would be input to expression quantitation and 
differential expression analysis. Cufflinks/CuffDiff (version 2.1.1) was used for expression 
quantitation and differential expression analysis, using Ensembl Oar_v3.1.fa as the reference 
genome sequence and Ensembl Oar_v3.1.gtf as the reference transcriptome annotation. 
Parameter settings used were: “--multi-read-correct” to adjust expression calculations for reads 
that map in more than one locus, “--compatible-hits-norm” and “--upper-quartile –norm” for 
normalization of expression values. This analysis resulted in FPKM (fragments per kilobase of 
transcript per million fragments mapped) values, fold changes, p-values, and q-values using the 
Benjamini-Hochberg False Discovery Rate (FDR) approach for multiple testing adjustment. 
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Differential expression was tested for BPA versus control (the effect of BPA), overfeeding 
(C+OF) versus control (the effect of overfeeding), and for BPA+OF versus C+OF (the effect of 
BPA in the presence of overfeeding). Diagnostic plots were generated using the CummeRbund 
package. 
 
Genes and transcripts satisfying three criteria (test status = “OK”, FDR < 0.10 and absolute value 
of fold change |FC | ≥ 1.5) were considered differentially expressed. For the set of differentially 
expressed genes (DEGs), hierarchical clustering with average linkage and correlation distance 
measures was performed to identify the main expression profiles observed across the four 
treatment conditions. Log-transformed expression levels were averaged over the four ewes for 
each condition, and then data were normalized by subtracting the overall average expression of 
each gene from each expression value. 
 
Functional enrichment testing: Enriched Gene Ontology (GO) terms, pathways and transcription 
factors, for each of the tested comparisons were tested using RNA-Enrich [Lee et al. 2015] 
(http://lrpath.ncibi.org/). RNA-Enrich tests for gene sets that have higher significance values 
(e.g. for differential expression) than expected at random, and takes into account any relationship 
between gene read count and significance level. By not requiring a cutoff for significance, RNA-
Enrich is able to detect both pathways with a few very significant genes and pathways with many 
only moderate differentially expressed genes. Because the sheep genome annotation lags far 
behind that of the human, the sheep Gene IDs were first converted to their orthologous human 
GeneIDs using Ensembl BioMart (http://www.ensembl.org/biomart/martview). A directional 
RNA-Enrich test (which tests for significantly up- versus down- regulated gene sets) was then 
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run for each comparison with the human orthologs and using default settings, with the following 
databases: Biocarta Pathway, EHMN metabolic pathways, Gene Ontology, KEGG Pathway, 
Panther Pathway, and transcription factors. Only concepts with less than 1000 genes were 
considered for this analysis. The LRpath clustering algorithm was then run to assess trends 
across the RNA-Enrich results using gene sets with FDR<0.01 in at least two of the three 
comparisons. RNA-Enrich results are in Figure 4 and in supplementary materials, including 
Table S2. The heatmap files (.ctd, .jtv, gtr, and atr) can be explored in an interactive format using 
Java TreeView (http://jtreeview.sourceforge.net/).  
 
Gene network building: To help interpret the biological relevance of the concepts significantly 
enriched, MetaCore [Nikolsky et al. 2005] software by Thomson Reuters was used to model 
interactions among the differentially expressed genes and genes in the top scoring concepts in 
each of the comparisons. In developing each of the networks, two sets of MetaCore parameters 
were used to develop parsimonious models of the interactions: 1- the shortest path algorithm 
with manually curated high-confidence interactions, and 2 - parameter settings as previously 
described [McEachin et al. 2010] where functional, binding and low-trust interactions were 
added (Supplementary Materials, Tables S3a,b,c network statistics for each model). 
 
Comparative Toxicogenomic Database (CTD) analysis: To understand the results in the context 
of previous BPA and cardiovascular disease-related literature, the results from this study were 
compared with relevant gene lists in the CTD database [Mattingly et al. 2003] 
(http://ctdbase.org/). CTD contains information relevant to understanding how environmental 
exposures affect human health at the molecular level; this includes interactions and relationships 
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among chemicals, genes/proteins, and diseases. For each of the comparisons, we found the 
intersection of the differentially expressed genes (FDR < 0.10) and the genes that are 
documented as being BPA responsive and related to cardiovascular diseases, hypertension, or 
obesity in the CTD database. 
 
Results 
Effect of prenatal BPA treatment and postnatal overfeeding on birth weight and body weight: 
Consistent with previous findings [Savabieasfahani et al. 2006] prenatal BPA treatment tended to 
reduce the birth weight of female offspring (Figure 1A; Control vs. BPA, p = 0.056). The 
average daily percent gain in body weight did not differ between control and prenatal BPA-
treated animals during the first two months. A significant increase in average daily percent gain 
in body weight was evident from 2-4 months of age in prenatal BPA treated animals relative to 
controls (Figure 1B). There was a trend for an increase in daily average percent gain in body 
weight in prenatal BPA-treated females relative to controls, when the first 14 weeks of life was 
considered (Figure 1C). At 14 weeks of age, just prior to the start of overfeeding, there was no 
significant difference in body weight between control and prenatal BPA treated groups (Figure 
1D). In the subset of females that were used for assessing cardiac tissue gene expression 
(n=4/group), overfeeding also increased body weight in both C+OF and BPA+OF groups to 
~30% more than their respective maintenance-fed animals (Figure 1E). The body weight was not 
different between the two maintenance-fed groups (control and BPA) or between the two overfed 
groups (C+OF, BPA+OF). Overfeeding significantly increased heart weight, when the entire 
group was considered [MohanKumar et al. 2016]. When analysis was restricted to the four 
animals used in the present study, this increase was statistically significant only between BPA 
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and BPA+OF groups (Figure 1F). Cohen’s effect size analysis revealed a large effect size in 
heart weights between Control and C+OF (d=1.0) and BPA and BPA+OF (d=1.2). 
 
There were 21,586 genes (20265 with human ortholog IDs) that had measurable transcript levels 
(FPKM > 0) in at least one sample, and 14,289 of these were successfully tested for differential 
expression as reported by CuffDiff. Of these, 263 genes (229 genes with human ortholog IDs) 
were significantly differentially expressed (FDR<0.10 and |FC| ≥ 1.5) in at least one of the 
comparisons. In particular, BPA treatment altered expression of 85 sheep genes (74 human 
ortholog IDs) under maintenance-fed conditions. Overfeeding altered expression of 141 genes 
(120 human orthologs) compared to control while only 112 genes (98 human orthologs) were 
altered in BPA+OF compared to C+OF (see Table S1 with list of all genes with human orthologs 
and DEGs by the test). The Venn diagram (Figure 2) shows the overlap between genes (human 
orthologues) that showed significant differential expression in each of the three comparisons. 
Seven genes (prostaglandin reductase 1 (PTGR1), carboxypeptidase, vitellogenic like (CPVL), 
natriuretic peptide receptor 3 (NPR3), family with sequence similarity 155 member B 
(FAM155B), alcohol dehydrogenase 1A (class I), alpha polypeptide (ADH1A), protease, serine 
35 (PRSS35), and major histocompatibility complex, class II, DQ alpha 1 (HLA-DQA1)) were 
significantly differentially expressed in all three tests. PTGR1 is involved in prostaglandin 
metabolism, CPVL is a protease expressed in inflammatory cells and endocrine tissues, NPR3 
regulates cardiac and circulatory functions, FAM155B is a transmembrane protein involved in 
calcium ion import, ADH1B is important in a number of metabolic pathways involving drugs 
and alcohol, PRSS35 is a protease with unknown function mostly highly expressed in female-
specific tissues, and HLA-DQA1 is involved in antigen presenting. 
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Under maintenance fed conditions, several genes important in regulation of growth of the 
myocardium were up-regulated by BPA, including genes involved in the FOXO and GATA1 
pathways, epidermal growth factor receptor signaling pathways, fibroblast growth factor receptor 
binding including the fibroblast growth factor 3 (FGFR3) gene and those of MAP kinase 
signalling, including transforming growth factor beta 3 (TGFB3) and fibroblast growth factor 18 
(FGF-18). BPA treatment also up-regulated genes involved in the WNT pathway that are 
involved in heart development and remodeling [Bergmann 2010], as well as those involved in 
histone modification. Down-regulated genes as a result of BPA exposure included those involved 
in oxidoreductase activity (e.g., acetyl-CoA acyltransferase 1 (ACAA1), glycerol-3-phosphate 
dehydrogenase 1 (GPD1), and cytochrome c oxidase subunit 7A1 (COX7A1)), and energy 
metabolism, which included genes involved in cellular respiration and the electron transport 
chain. Downregulation of genes invoved in the inflammation process and extracellular space 
were also evident. With overfeeding, genes up-regulated by BPA included those involved in 
muscle contraction, p38 MAPK pathway, positive regulation of JNK, cellular response to TNF 
and oxidoreductase activity. However, genes involved in fibroblast growth factor receptor 
binding were down-regulated. Interestingly, the pattern of cardiac relevant upregulated genes 
with BPA treatment were similar to the overfed animals; these included genes involved in 
growth mentioned above and also those genes involved in histone modification. Overfeeding 
alone upregulated genes involved in the apoptosis pathway, and downregulated genes involved 
in energy metabolism, inflammation pathways and actin mediated contraction genes similar to 
BPA effects (Table I). 
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Clustering of the differentially expressed genes across the four treatments revealed a complex 
relationship between the effects of BPA and overfeeding (Figure 3). Very few genes exhibited a 
similar response to BPA under the postnatal maintenance fed and overfed conditions. Instead, 
BPA in the presence of overfeeding most often had an opposite effect compared to BPA under a 
maintenance fed diet. A set of genes unchanged by BPA was down-regulated in C+OF ewes and 
up-regulated in BPA+OF (cluster V). Since the expected combined effect of BPA and OF - given 
independently acting individual effects would also be down-regulation - this result is indicative 
of an interaction effect between BPA and overfeeding on gene expression; this group included 
fatty acid binding protein 4 (FABP4), alpha-2-macroglobulin (A2M) and apolipoprotein D 
(APOD), and also several genes belonging to the major histocompatibility complex (HLA-C, 
HLA-DQA1 and HLA-DRB1). FABP4 regulates fatty acid uptake, transport, or metabolism in 
adipocytes, A2M is a protease inhibitor and cytokine transporter, and APOD is a component of 
high density lipoprotein. Another group of genes (cluster VII) was down-regulated in the C+OF 
and BPA groups, but up-regulated in BPA+OF, also indicative of a strong interaction effect of 
BPA and overfeeding. This group of genes included several that play a role in cardiovascular 
function e.g. adrenoceptor beta 3 (ADRB3), plasminogen activator, urokinase receptor (PLAUR), 
limbic system-associated membrane protein (LSAMP) and NPR3. ADRB3 is located primarily in 
the small intestine, adipose tissue and vascular endothelium and involved in the regulation of 
lipolysis and thermogenesis; PLAUR plays a role in localizing and promoting plasmin formation; 
LSAMP mediates selective neuronal growth and axon targeting in the developing limbic system. 
A large group of genes was strongly up-regulated in C+OF and BPA groups compared to 
control, but partially or completely reversed in the BPA+OF group (cluster IV). This group 
included the genes immunoglobulin superfamily, member 10 (IGSF10), interleukin 32 (IL32) 
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and S100 calcium binding protein B (S100B). IGSF10 may be involved in the maintenance of 
osteochondroprogenitor cells pool; IL32 induces various cytokines such as TNF-alpha and IL8 
and activates typical cytokine signal pathways of NF-kappa-B and p38 MAPK; S100B proteins 
are involved in the regulation of a number of cellular processes such as cell cycle progression 
and differentiation. 
 
Functional enrichment results: Functional enrichment testing using RNA-Enrich found the top 
scoring gene sets downregulated by overfeeding were related to the extracellular space (FDR= 
7.88E-16), oxidation-reduction process (FDR= 1.24E-12), and also to the ribosome, endoplasmic 
reticulum, and processes related to translation. Conversely, the most significant terms 
upregulated by overfeeding were related to transcription factor activity (FDR= 4.84E-13) and 
chromosome organization (FDR= 2.97E-08). Under maintenance-fed conditions, terms related to 
ribosome, extracellular region, mitochondrion (FDR for these concepts varied from 3.77E-18 to 
1.89E-13) and inflammatory response (FDR=1.51E-09), were downregulated by BPA. The top 
scoring gene sets up-regulated by BPA were chromosome/chromatin organization and embryo 
development (FDR=2.31E-06 and 8.09E-05, respectively), which overlapped with the response 
for overfeeding. The top scoring terms upregulated in BPA+OF groups compared to C+OF 
group were related to mitochondrion, oxidoreductase activity, and 5-hydroxytryptomine 
degradation (FDRs ranged from 2.65E-06 to 2.99E-04) (Table S2 and Table I). Visualization of 
the heatmap of enriched gene sets revealed extensive similarities between the effect of 
overfeeding and the effect of BPA under maintenance-fed conditions (Figure 4). Metabolic 
processes, histone modifications, WNT signaling and other embryo development processes were 
upregulated by both, while oxidoreductase activity, immune, chemokine, and inflammatory 
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response, and proteins located in the endoplasmic reticulum and mitochondrion were 
downregulated by both. In contrast to BPA-treatment with maintenance diet, the combination of 
prenatal BPA-treatment and postnatal overfeeding prevented some effects of postnatal 
overfeeding alone. Genes related to ATP synthase, immune response and mitochondrion were 
reduced by either BPA or overfeeding alone, but reversed to higher expression in BPA+OF. 
Conversely, gene sets related to metabolic and biosynthetic processes or regulation of 
transcription were increased by either BPA or overfeeding alone, but reversed to lower 
expression in BPA+OF.  
 
Gene network models: To place the significant genes in biological context, the significant DE 
genes from each of these tests (BPA vs. control, C+OF vs. control, and BPA+OF vs. C+OF) 
were analyzed in MetaCore and a protein interaction network was constructed for each. For 
network construction, two sets of parameters were used: a) only high-confidence interactions; 
and b) high-confidence interactions with binding and low-trust interactions. The three networks 
derived from the three experiments were combined to present nodes specific and shared for every 
network (Figure 5). The BPA vs. control network (see Figure 5, green nodes and edges) included 
two main hubs: early growth response 1 (EGR1) and Fos proto-oncogene, AP-1 transcription 
factor subunit (FOS) (network object AP-1 on Figure 5). EGR1 is a transcriptional regulator 
which activates the transcription of target genes whose products are required for mitogenesis and 
differentiation. FOS participates in forming the transcription factor complex AP-1 and has been 
implicated as regulators of cell proliferation, differentiation, and transformation. In the BPA vs. 
control network these two hubs interact both directly - i.e. EGR1 binds to gene c-Fos promoter 
and activates c-Fos expression [Ishikawa et al. 2007] - and through other genes/proteins, such as 
regulator of G-protein signaling 2 (RGS2), PLAUR, tyrosine 3-monooxygenase (TY3H), and 
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others. RGS2 plays a role in the regulation of blood pressure in response to signaling via G 
protein-coupled receptors and GNAQ (G protein subunit alpha q); TY3H plays an important role 
in the physiology of adrenergic neurons. TY3H and PLAUR were identified as additional new 
hubs in the BPA vs. control network when functional and low-trust interactions were used for 
network construction (Table S3-a). 
 
The C+OF vs. control network (Figure 5, blue nodes and edges) includes three main hubs: 
epidermal growth factor receptor (EGFR), FOS (network object AP-1), and Fas cell surface 
death receptor (FAS, network object FasR-CD95). EGFR is a cell surface protein that binds to 
epidermal growth factor and activates several signaling cascades including RAS-RAF-MEK-
ERK, PI3 kinase-AKT, PLCgamma-PKC and STATs modules; FAS is a member of the TNF-
receptor superfamily and play a central role in the physiological regulation of programmed cell 
death. Low-trust interactions additionally identified protein kinase C gamma (gene PRKCG, 
network object PKC), clock circadian regulator (CLOCK), and A2M as hubs (Table S3-b). PKC 
family members phosphorylate a wide variety of protein targets and play roles in modulation of 
receptors and neuronal functions related to sensitivity to opiates, pain and alcohol, mediation of 
synaptic function and cell survival after ischemia, and inhibition of gap junction activity after 
oxidative stress; CLOCK plays a central role in the regulation of circadian rhythms and 
associated with obesity and metabolic syndrome [Corella et al. 2016]. 
 
The network derived from BPA+OF vs. C+OF gene set had less connectivity among nodes 
compared with the two previous ones (Figure 5, red nodes and edges). There were no hubs in this 
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network using high-trust interactions, but AP-1 was again identified as a hub when using low-
trust interactions (Table S3-c).  
Although the differentially expressed genes in each of these three comparisons were mostly 
different, the networks that they participate in show important overlaps. Specifically, nuclear 
AP-1 is a significant interacting transcription factor and a hub in all three networks. PKC is an 
important regulator of cardiac function and a hub in C+OF vs. control and PKC also has 
connections in the BPA+OF vs. C+OF network.  
 
Overlaps with Comparative Toxicogenomic Database (CTD): Given the large numbers of 
potentially interesting genes, genes were prioritized based on the overlap between the differential 
expresssion results and CTD annotations. For each of the three comparisons, genes that were 
both differentially expressed and annotated for cardiovascular diseases and/or BPA response in 
the CTD were determined (Table II). Most of the overlapping genes were involved in signal 
transduction and transcriptional regulation, consistent with a fundamental cellular response to 
environmental stimulus. An interesting result is that FOS, EGR1, FAS are found to overlap with 
genes associated with bisphenol A and cardiovascular diseases (from CTD), and they were also 




The findings from this study demonstrate that prenatal BPA treatment, postnatal 
overfeeding/adiposity and their combination lead to transcriptional changes in the myocardium 
of female sheep. Although the transcriptional dysregulation induced by prenatal BPA treatment 
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and overfeeding did not involve the same genes for the most part, the biological pathways they 
affected were remarkably similar. Paradoxically, while the combined treatment failed to produce 
an additive or synergistic response, prenatal BPA treatment prevented in part the effects of 
overfeeding. Prenatal BPA treatment altered genes previously known to be involved in obesity, 
hypertension, or heart disease. The main hubs that were affected by BPA and/or overfeeding 
include AP-1, EGR1, and EGFR. 
 
Impact of prenatal BPA exposure on cardiovascular system: Recent epidemiogical studies 
indicate that prenatal BPA treatment is associated with adverse cardiovascular outcomes [Gao 
and Wang 2014] with a positive correlation existing between BPA exposure and vascular 
disease, including coronary artery disease and hypertension [Lang et al. 2008; Bae et al. 2012]. 
Prolonged BPA exposure throughout the lifespan has also been found to increase mean arterial 
pressure in female rats [Patel et al. 2013]. To our knowledge data is sparse relative to the effects 
of prenatal BPA exposure on the cardiovascular system in the offspring. A recent study found 
prenatal BPA treatment to induce transcriptome changes in the fetal heart suggestive of adverse 
cardiac programming in rhesus monkeys [Chapalamadugu et al. 2014]. Importantly, using the 
same cohort of animals that included animals used in the present study, we recently found 
prenatal BPA treatment increased atrial natriuretic peptide (ANP), a marker of left ventricular 
hypertrophy frequently associated with systemic hypertension, in the left ventricle without 
having an effect on blood pressure [MohanKumar et al. 2016]. This could signify the direct 
effect of BPA on the left ventricular structure and not secondary to hypertrophic stimuli. In our 
current study BPA downregulated Naturetic Peptide Receptor 3 (NPR3) gene within the left 
ventricular myocardium and since NPR system has been shown to play a role in intrinsic growth 
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of the myocardium [Matsukawa et al. 1999; Becker et al. 2014] these findings coupled with our 
earlier finding of elevated ANP raise the possibility of direct effect of BPA on the NPR system 
within the left ventricle. 
On the one hand, the lack of hypertensive effects in the face of increased left ventricular ANP 
levels may be a function of the younger age (21 months) at which blood pressure measures were 
undertaken. Alternatively, since subtle perturbations in blood pressure are better measured with 
continuous radio telemeters - rather than a single time point measurement such as that use in this 
study - the impact on blood pressure could have been missed. Further studies detailing structural 
and cardiovascular functional changes at multiple developmental time points obtained under 
cardiac stress conditions - an understudied area - would help elucidate the detrimental effects of 
prenatal BPA exposure on cardiovascular system. The current study, an extension of the previous 
study at the functional level [MohanKumar et al. 2016], is the first step in this direction and 
provides a more global perspective of molecular pathways that are altered within the left 
ventricular myocardium from prenatal exposure to BPA. 
 
Our present findings also provide evidence in support of prenatal BPA treatment having an 
impact on genes involved in obesity, hypertension, and cardiovascular disease. The key hub, 
AP1, affected by prenatal BPA treatment, regulates numerous cellular processes including 
proliferation, cellular differentiation and apoptosis [Ye et al. 2014]. The AP-1 pathway is 
involved in extracellular matrix changes leading to fibrosis, contractile dysfunction and also 
cardiac hypertrophy [Shaulian and Karin 2002; Hill et al. 2013].  
 
The second hub that was affected by prenatal BPA treatment involved EGR1, a master regulator 
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belonging to the zinc finger transcription factor family. EGR1 regulates cell proliferation, 
differentiation and apoptosis and is rapidly induced by various stimuli including hypoxia, growth 
factors, cytokines, and injurous stimuli [Khachigian 2006]. EGR1 has been linked to 
cardiovascular pathologies including cardiac hypertrophy, atherosclerosis [Khachigian 2006]. 
EGR1 silencing has been found to reduce myocardial insult, inflammation and apoptosis [Rayner 
et al. 2013]. The downregulation of the EGR1 gene and the reduction in the inflammtory 
response pathway evident in prenatal BPA treated animals might therefore represent a 
compensatory response to overcome adverse changes in the myocardium that are not yet evident 
at a structural or functional level in these postpubertal animals.  
 
Other pathways relevant to left ventricular function and structure that were altered by prenatal 
BPA treatment included downregulation of pathways associated with mitochondrial function 
including oxidoreductase activity, protein targeting to ER, the oxidation-reduction process, those 
involved with protein biosynthesis including translational and elongation, muscle contraction, 
and the inflammatory response including p38MAPK cascade and the JNK cascade. The 
upregulated pathways included those involved with development of cardiac muscle tissue and the 
WNT pathway, which is involved in cardiac hypertrophy and remodeling [Bergmann 2010]. 
 
Our finding of downregulation of pathways involved in mitochondrial function in left ventricular 
myocardium in prenatal BPA-treted animals is consistent with earlier findings of such 
dysfunction in neonatal cardiomyocytes of prenatal BPA-treated animals [Jiang et al. 2015]. 
Mitochondrial dysfunction, which includes gene sets involved in regulation of mitochondrial 
inner membrane, respiratory electron chain, and oxidoreductase activity that are vital for cardiac 
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function and cardiac failure over time [Khan et al. 2015], is a known target for EDCs including 
BPA [Xia et al. 2014]. Additional prenatal BPA-induced disruptions include downregulation of 
pathways associated with cardiac contractility, such as those associated with actin-myosin 
filament sliding and myofilament function, which can lead to disruptions in myocardial 
mechanical properties and contractile functions [Moss et al. 2004]. 
 
Pathways associated with epigenetic changes including histone modification [Cheung and Lau 
2005] and chromosome organization were also targets of prenatal BPA treatment, suggestive of 
epigenetic changes underlying such transcriptional changes. An earlier study found early 
postnatal BPA exposure induced epigenetic changes such as hypermethylation of the 
mitochondrial gene PGC-1 alpha leading to cardiomyopathy in male rats [Jiang et al. 2015].  
 
Impact of postnatal adiposity: It is well known that obesity is detrimental to cardiovascular 
health. In clinical studies, it has been shown that obesity leads to hypertension and cardiac 
remodelling including eccentric cardiac hypertrophy and cardiac dysfunction over time [Poirier 
et al. 2006; Abel et al. 2008]. Obesity during early life has also been implicated in the 
development of cardiovascular disease including cardiac remodeling and left ventricular 
hypertrophy [Nadeau et al. 2011; Shah et al. 2011]. Mechanisms for adverse cardiac remodeling 
due to obesity are not completely understood, but evidence exists in support of perturbations in 
cardiac metabolism, mitochondrial dysfunction and oxidative stress [Abel et al. 2008]. Findings 
from the present study are consistent with cardiac remodeling in that overfeeding resulted in 
increased heart weight in the subset of prenatal BPA-treated animals subjected to transcriptome 
analyses, along with downregulation of pathways involved in mitochondrial function, such as 
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mitochondrial respiratory chain, and upregulation of pathways associated with cell growth, such 
as FOXO and GATA pathways that have been linked to cardiac hypertrophy [Kohli et al. 2011].  
 
Strikingly the changes in gene sets evidenced in overfed animals paralleled many of the changes 
seen in prenatal BPA-treated females including the key hubs affected. The key gene hub affected 
by overfeeding, AP-1, was also a target of prenatal BPA-treatment. The effects of overfeeding 
namely an increase in FOS as opposed to a decrease in prenatal BPA-treated females is 
consistent with finding that long-term high-fat diet up-regulates the AP-1 transcription factor c-
fos [Foldes et al. 2006]. Apart from members of the AP-1 family, pathways relevant to left 
ventricular function and structure that were affected by prenatal BPA treatment were also 
affected in the C+OF group. These include downregulation of pathways associated with 
mitochondrial function, protein biosynthesis, muscle contraction and the inflammatory response 
and upregulation of pathways involved in cardiac muscle tissue development, cardiac 
hypertrophy [Bergmann 2010], epigenetic changes, and apoptosis, all supportive of adverse 
cardiac remodeling. It is well-known that adverse cardiac remodelling leads to poor cardiac 
efficiency [Abel et al. 2008]. EGFR, which is linked to adverse cardiovascular dysfunction 
including hypertension and cardiac hypertrophy [Smith et al. 2004; Forrester et al. 2016; Peng et 
al. 2016], was an additional hub that was affected by overfeeding. 
 
Prenatal BPA and postnatal diet interaction: Contrary to the premise that prenatal BPA 
treatment would accentuate the adverse cardiac effects observed with overfeeding, prenatal BPA 
treatment prevented the effects of overfeeding, albeit partially; the transcriptome changes seen in 
BPA+OF group differed from prenatal BPA and C+OF groups. Pathways downregulated in BPA 
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and C+OF groups were either upregulated in BPA+OF group or not significantly altered. While 
pathways involved in mitochondrial function (oxidoreductase activity, oxidation-reduction 
process) were upregulated, those involved in epigenetic modification, protein synthesis, muscle 
contraction, and inflammation that were altered in the BPA and C+OF group were not altered in 
the BPA+OF group. Our recent findings [MohanKumar et al. 2016] with the cohort of animals 
that included animals used in the present study found prenatal BPA treatment prevented the 
effects of postnatal overfeeding in increasing blood pressure and left ventricular area. These 
findings add functional linkage to the findings at the gene level (present study). Similar to these 
paradoxcial interactions, a recent study found that a high-fat diet mitigated the adverse effects of 
BPA on embryo implantation [Martinez et al. 2015]. In recent years it has become increasingly 
clear that the manifestation of a final phenotypic outcome is not merely dictated by the 
organizational changes that occur during critical periods of differentiation such as those induced 
by BPA in this study, but also is a function of the prevailing postnatal milieu [Puttabyatappa et 
al. 2015]. Additional studies addressing whether these unexpected findings in the BPA+OF 
group are adaptive or maladaptive would further our understanding of the interaction between 
prenatal BPA exposure and the postnatal environment in modulating cardiac function and 
identifying preventive treatment strategies.  
 
Strength of bioinformatics approach: From a bioinformatics perspective, while this would have 
been a fairly straight-forward study in humans, the use of sheep presented an annotation 
challenge. However, the use of human orthologs dramatically increased the ability to 
functionally interpret the results. In addition, the use of RNA-Enrich ensured that we were not 
merely identifying functions with highly-expressed or long genes, which have more statistical 
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power to detect differential expression. Finally, Metacore network analysis enabled comparison 
of the interaction networks of the three effects of interest: BPA, BPA in the presence of 
overfeeding, and overfeeding alone, while CTD provided a disease- and exposure-specific 
contextual foundation for comparison. 
 
Translational relevance: Considering the ubiquitous presence of BPA in consumer products and 
its ability to function through steroid /insulin receptors [Vandenberg et al. 2010], findings from 
this study are likely to be of both clinical and public health relevance. Importantly, the BPA dose 
used in this study produced fetal blood levels of BPA well within the range seen in maternal 
circulation [Padmanabhan et al. 2008] and urine [Calafat et al. 2005] of US women. Because of 
concerns raised regarding the widespread use of altricial rodent models for risk assessments of 
EDCs in humans [Habert et al. 2014], use of sheep in this study, a precocial model with similar 
fetal developmental trajectory as humans [Padmanabhan and Veiga-Lopez 2013] extensively 
used for understanding developmental origins of metabolic diseases [Green et al. 2010; 
Nathanielsz et al. 2013; Cardoso et al. 2015] are likely valuable for human translation. 
Importantly, the chosen window of exposure corresponds with developmental periods of 
differentiation of metabolic systems in the female sheep [Padmanabhan and Veiga-Lopez 2013], 
and has been shown to be a critical period for producing metabolic perturbations including 
insulin resistance [Cardoso et al. 2015] and hypertension [King et al. 2007]. Previously we found 
that this exposure level of BPA induced (in sheep and rats) or was associated with (in human) 
fetal oxidative stress [Veiga-Lopez et al. 2015b] and low birth weight offspring [Veiga-Lopez et 
al. 2015a], risk factors for adult onset cardiometabolic diseases [Yajnik 2000; Varvarigou 2010; 
Perrone et al. 2016]. The trend for reduced birth weight in prenatal BPA-treated female offspring 
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in this study, a finding in agreement with our previous studies in sheep [Savabieasfahani et al. 
2006] and other studies in rodents [Ranjit et al. 2010], raises the possibility that the effects of 
prenatal BPA exposure may be the consequence of intrauterine growth restriction of the 
developing fetus. Future studies are needed to illuminate to what extent the effects of BPA on 
cardiac function is due to its direct effects on the developing heart as opposed to those 
programmed via altered fetal growth trajectory. Studies of the interaction of prenatal BPA and 
postnatal overfeeding are also valuable considering the obesity epidemic facing the nation [Smith 
and Smith 2016] and the potential for an altered metabolic milieu in modulating the 
manifestation or severity of prenatally programmed cardiometabolic dysfunctions [Kim et al. 
2015; Padmanabhan et al. 2016]. 
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Table I. Enriched gene sets for three comparisons: BPA vs. Control, C+OF vs. Control, and BPA+OF vs. C+OF. The first 20 gene sets 
are the top most significant in at least one comparison. The remaining 15 gene sets are related to the cardiovascular system and 
significant in at least one comparison. Numbers in parentheses for Gene Set Type represent the number of analyzed genes in the gene 
set; numbers in parentheses for Direction are the number of significant genes in that category for the corresponding comparison. 
 
No Gene Set ID Gene Set Name Gene Set Type 
(Size) 









1 GO:0016491 oxidoreductase activity GOMF (724) down (53) 9.96E-12 down 
(102) 
2.05E-13 up (40) 2.78E-05 
2 GO:0045047 protein targeting to ER GOBP (84) down (16) 3.10E-11 down (40) 7.92E-21 down 
(3) 
8.01E-02 
3 GO:0055114 oxidation-reduction process GOBP (935) down (78) 4.79E-11 down 
(127) 
1.24E-12 up (57) 1.09E-05 
4 GO:0006414 translational elongation GOBP (87) down (19) 2.09E-08 down (43) 1.71E-17 down 
(3) 
2.93E-01 
5 GO:0051276 chromosome organization GOBP (952) up (26) 2.31E-06 up (53) 2.97E-08 down 
(11) 
1.08E-01 
6 GO:0016570 histone modification GOBP (393) up (15) 1.33E-03 up (34) 2.82E-05 down 
(4) 
3.79E-01 
7 GO:0006936 muscle contraction GOBP (283) down (25) 2.80E-01 down (40) 5.77E-01 up (20) 7.86E-04 
8 GO:0006954 inflammatory response GOBP (452) down (34) 1.51E-09 down (39) 8.59E-06 up (22) 1.24E-02 
9 GO:0038066 p38MAPK cascade GOBP (12) down (1) 8.28E-01 down (3) 4.71E-01 up (3) 1.10E-03 
10 GO:0046330 positive regulation of JNK 
cascade 
GOBP (52) down (6) 9.92E-01 down (7) 3.51E-01 up (8) 1.03E-03 
11 GO:0003735 structural constituent of 
ribosome 
GOMF (111) down (22) 3.77E-18 down (53) 2.85E-28 down 
(3) 
9.90E-01 
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2 GO:0006614 SRP-dependent 
cotranslational protein 
targeting to membrane 
GOBP (77) down (16) 2.93E-11 down (40) 7.92E-21 down 
(3) 
7.16E-02 
3 GO:0005615 extracellular space GOCC (722) down ( 88) 1.89E-13 down 
(108) 
7.88E-16 up (65) 4.29E-02 
4 GO:0005743 mitochondrial inner 
membrane 
GOCC (417) down (26) 2.34E-10 down (59) 3.42E-11 up (11) 3.56E-03 
5 GO:0044429 mitochondrial part GOCC (938) down (4 5) 1.52E-09 down (98) 1.42E-10 up (32) 2.99E-04 
6 GO:0022904 respiratory electron 
transport chain 
GOBP (127) down (12) 5.50E-09 down (28) 8.45E-11 up (4) 2.21E-01 
7 GO:0002685 regulation of leukocyte 
migration 
GOBP (95) down (8) 4.44E-02 down (13) 1.10E-02 up (10) 1.54E-03 
8 GO:0001071 nucleic acid binding 
transcription factor activity 
GOMF (883) up (39) 8.77E-05 up (69) 4.84E-13 down 
(21) 
7.94E-02 
9 GO:0042044 fluid transport GOBP (31) up (5) 7.44 E-02 up (3) 1.22E-01 down 
(3) 
2.39E-03 
0 882901 5-Hydroxytryptamine 
degradation 
Panther (14) down (1) 3.79E-01 down (3) 3.04E-01 up (4) 2.65E-06 
1 GO:0055024 regulation of cardiac 
muscle tissue development 
GOBP (41) up (3) 9.58E-03 up (6) 1.03E-02 down 
(1) 
9.95E-01 
2 GO:0055015 ventricular cardiac muscle 
cell development 
GOBP (11) up (1) 2.75E-02 up (3) 3.50E-01 down 
(1) 
9.40E-01 
3 GO:0021591 ventricular system 
development 
GOBP (21) up (1) 4.74E-02 up (2) 4.19E-02 down 
(1) 
3.71E-01 
4 GO:0033275 actin-myosin filament 
sliding 
GOBP (40) down (5) 5.11E-05 down (4) 9.37E-05 up (1) 2.53E-01 
5 hsa04310 Wnt signaling pathway KEGG (119) up (4) 6.63E-03 up (12) 8.84E-03 down 
(6) 
3.49E-01 
6 882841 Endothelin signaling 
pathway 
Panther (64) up (5) 1.70E-02 up (8) 3.90E-01 down 
(2) 
4.66E-01 
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7 GO:0061061 muscle structure 
development 
GOBP (525) up (30) 5.06E-01 up (60) 2.17E-02 down 
(19) 
9.83E-01 
8 882953 Apoptosis signaling 
pathway 
Panther (95) up (5) 8.64E-01 up (12) 1.82E-02 down 
(7) 
2.13E-01 
9 GO:0007173 epidermal growth factor 
receptor signaling pathway 
GOBP (202) up (13) 2.91E-02 up (30) 8.32E-06 down 
(9) 
1.63E-01 
0 GO:0005104 fibroblast growth factor 
receptor binding 
GOMF (11) up (1) 2.00E-03 up (3) 1.92E-04 down 
(1) 
1.81E-02 
1 884942 FOXO1_02 TFs (225) up (13) 5.15E-04 up (2 8) 2.40E-04 down 
(7) 
1.84E-01 
2 885009 FOXO3_01 TFs (174) up (11) 1.55E-02 up (1 6) 9.45E-03 down 
(4) 
1.01E-01 
3 884988 GATA1_05 TFs (151) up (13) 1.55E-02 up (2 2) 2.98E-03 down 
(9) 
8.25E-01 
4 hsa04010 MAPK signaling pathway KEGG (220) up (1 2) 1.17E-02 up (34) 5.43E-04 down 
(18) 
9.96E-01 
5 GO:0071356 cellular response to tumor 
necrosis factor 
GOBP (82) down (6) 1.94E-01 down (14) 5.80E-02 up (9) 1.54E-03 
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Table II. Differentially expressed genes that overlap with genes from the Comparative 
Toxicogenomic Database (CTD; http://ctdbase.org/) associated with the term “Bisphenol A” and 
the listed Diseases. The term “Cardiovascular Diseases” (9th row) includes: Hypotension (52 
genes), Arrhythmias Cardiac (18), Hypertension (172), Myocarditis (5), Ventricular Premature 
Complexes (1), Vascular Diseases (16), Atherosclerosis (50), Cardiomegaly (64), Heart Defects 
Congenital (30), and Cardiomyopathy Hypertrophic (20 genes).  
Genes from CTD: BPA 
& Disease (# genes) 
BPA vs Control (75)
a C+OF vs Control 
(122)
a 
BPA+OF vs C+OF 
(98)
a 
Bisphenol A & Heart 
Failure (76) 
1 (ADRB3) 2(ADRB3, GATM) 1 (GATM) 
Bisphenol A & 
Cardiomyopathies (65) 
0 1 (FAS) 0 
Bisphenol A & 
Myocardial Infarction 
(82) 
0 0 1 (S100B) 
Bisphenol A &  
Myocardial Ischemia 
(167) 
0 2(GATM, HSPA1A) 
3(GATM, TFRC, 
UQCRFS1) 
Bisphenol A &  
Ventricular 
Dysfunction, Left (13) 
0 1(FAS) 0 
Bisphenol A &  
Cardiomegaly (64) 
1 (UCP2) 0 0 
Bisphenol A & 
Hypertension (172) 
5 (APOA1, FOS, NCF1, 
RGS2, UCP2 ) 
3 (FOS, NCF1, 
STK39) 
0 
Bisphenol A & Obesity  
(148) 
2 (ADRB3, UCP2) 1 (ADRB3) 2 (ALDH1L1, TFRC) 
Bisphenol A &  
Cardiovascular Diseases 
(325) 
5 (APOA1, FOS, NCF1, 
RGS2, UCP2) 




Bisphenol A (273) 
5 (APOA1, EGR1, FOS, 
LPAR1, TH) 
2 (FAS, FOS) 2 (C3, FABP4) 
aGene names and functions (those not mentioned earlier): ALDH1L1 (aldehyde dehydrogenase 1 family, 
member L1) loss of function or expression of this gene is associated with decreased apoptosis, increased 
cell motility, and cancer progression; APOA1 (apolipoprotein A-I) promotes cholesterol efflux from 
tissues to the liver for excretion, and is a cofactor for lecithin cholesterolacyltransferase (LCAT), an 
enzyme responsible for the formation of most plasma cholesteryl esters; C3 (complement component 3) 
C3 peptide modulates inflammation and possesses antimicrobial activity; DRD1 (dopamine receptor D1) 
this G-protein coupled receptor stimulates adenylyl cyclase and activates cyclic AMP-dependent protein 
kinases; GATM (glycine amidinotransferase) catalyzes the biosynthesis of guanidinoacetate, the 
immediate precursor of creatine which plays a vital role in energy metabolism in muscle tissues; HSPA1B 
(heat shock 70kDa protein 1B) participate in stabilizing of existing proteins against aggregation and 
mediates the folding of newly translated proteins in the cytosol and in organelles; LPAR1 
(lysophosphatidic acid receptor 1) plays a role in the reorganization of the actin cytoskeleton, cell 
migration, differentiation and proliferation, and thereby contributes to the responses to tissue damage and 
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infectious agents; MAOB (monoamine oxidase B) the protein catalyzes the oxidative deamination of 
biogenic and xenobiotic amines and plays an important role in the metabolism of neuroactive and 
vasoactive amines in the central nervous system and peripheral tissues; NCF1 (neutrophil cytosolic factor 
1) the protein is subunit of neutrophil NADPH oxidase; STK39 (serine threonine kinase 39) acts as a 
mediator of stress-activated signals; TFRC (transferrin receptor) participates in cellular iron uptake by the 
process of receptor-mediated endocytosis; TH (tyrosine hydroxylase) protein is involved in the conversion 
of tyrosine to dopamine and plays a role in the physiology of adrenergic neurons; UCP2 (uncoupling 
protein 2) protein separate oxidative phosphorylation from ATP synthesis with energy dissipated as heat - 
mitochondrial proton leak; UQCRFS1 (ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 
1) ubiquinol-cytochrome c reductase complex is a respiratory chain that generates an electrochemical 
potential coupled to ATP synthesis. 
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Figure 1. Birth weight (A), average daily percent gain in body weight from 0-2 and 2-4 months 
of age (B), body weight at 14 weeks of age (C), body weight at start of overfed diet (D) and at 
the time of euthanasia (E), and heart weight (F) comparisons between control and prenatal BPA-
treated female sheep that received either maintenance diet or were overfed starting from 14 
weeks of age. Data are presented as mean ± SEM. * = p< 0.05. Panel E: Different superscripts (a 
vs. b) indicates significant differences. 
 
Figure 2. Comparison of differentially expressed genes (FDR<0.10 and |FC|≥1.5) between three 
tests: BPA vs. Control, overfeeding (C+OF) vs. Control and BPA+OF vs. C+OF. Presented are 
the number of human ortholog IDs for sets of differentially expressed genes and number of up- 
and down-regulated genes for each comparison. 
 
Figure 3. Heatmap from hierarchical clustering of significant differentially expressed genes 
(FDR< 0.10 and |FC|≥1.5) for at least one of the three comparisons performed: BPA vs. Control, 
C+OF vs. Control and BPA+OF vs. C+OF. The expression values (FPKMs) of the DEGs for the 
four treatment conditions were log transformed and clustered using criteria indicated in Materials 
and Methods. Genes listed at right belong to the respective cluster and were chosen based on 
their association with cardiovascular diseases according to the MetaCore database. 
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Figure 4. Heatmap from hierarchical clustering of significant gene sets from functional 
enrichment testing. Gene sets with FDR<0.01 in at least two of the three comparisons were used 
in clustering. Boxes highlight the main types of gene sets enriched in each cluster. 
 
Figure 5. The combined protein interaction network illustrating the response for BPA vs. 
Control (green nodes and edges), OF vs. Control (blue), and BPA+OF vs. C+OF (red). The 
network was constructed from the subnetworks of differentially expressed genes with direct, 
high-confidence interactions from each of the three comparisons. The combination of the node’s 
colors indicates that the node is involved in more than one subnetwork: for example AP-1 
combined green, blue and red colors meaning that this hub is involved in all three subnetworks. 
PKC is involved in OF vs. Control and BPA+OF vs. C+OF (combination of blue and red colors). 
Teal and purple edge colors represent interactions observed in both green and blue, or red and 
blue, respectively (e.g., the purple edge between AP-1 and LAMC2). A legend for the shapes 
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Figure 1. Birth weight (A), average daily percent gain in body weight from 0-2 and 2-4 months of age (B), 
body weight at 14 weeks of age (C), body weight at start of overfed diet (D) and at the time of euthanasia 
(E), and heart weight (F) comparisons between control and prenatal BPA-treated female sheep that received 
either maintenance diet or were overfed starting from 14 weeks of age. Data are presented as mean ± SEM. 
* = p< 0.05. Panel E: Different superscripts (a vs. b) indicates significant differences.  
Consistent with previous findi  
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Figure 2. Comparison of differentially expressed genes (FDR<0.10 and |FC|≥1.5) between three tests: BPA 
vs. Control, overfeeding (C+OF) vs. Control and BPA+OF vs. C+OF. Presented are the number of human 
ortholog IDs for sets of differentially expressed genes and number of up- and down-regulated genes for 
each comparison.  
The Venn diagram (Figure 2) sh  
246x197mm (72 x 72 DPI)  
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Figure 3. Heatmap from hierarchical clustering of significant differentially expressed genes (FDR< 0.10 and 
|FC|≥1.5) for at least one of the three comparisons performed: BPA vs. Control, C+OF vs. Control and 
BPA+OF vs. C+OF. The expression values (FPKMs) of the DEGs for the four treatment conditions were log 
transformed and clustered using criteria indicated in Materials and Methods. Genes listed at right belong to 
the respective cluster and were chosen based on their association with cardiovascular diseases according to 
the MetaCore database.  
Clustering of the differential  
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Figure 4. Heatmap from hierarchical clustering of significant gene sets from functional enrichment testing. 
Gene sets with FDR<0.01 in at least two of the three comparisons were used in clustering. Boxes highlight 
the main types of gene sets enriched in each cluster.  
The LRpath clustering algorith  
246x282mm (72 x 72 DPI)  
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Figure 5. The combined protein interaction network illustrating the response for BPA vs. Control (green 
nodes and edges), OF vs. Control (blue), and BPA+OF vs. C+OF (red). The network was constructed from 
the subnetworks of differentially expressed genes with direct, high-confidence interactions from each of the 
three comparisons. The combination of the node’s colors indicates that the node is involved in more than 
one subnetwork: for example AP-1 combined green, blue and red colors meaning that this hub is involved in 
all three subnetworks. PKC is involved in OF vs. Control and BPA+OF vs. C+OF (combination of blue and red 
colors). Teal and purple edge colors represent interactions observed in both green and blue, or red and blue, 
respectively (e.g., the purple edge between AP-1 and LAMC2). A legend for the shapes used for the nodes is 
provided in MetaCore Quick Refernce Guide https://ftp.genego.com/files/MC_legend.pdf  
The three networks derived fro  
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